Skill Checkup: A 32-Year-Old Man With an Acute Flare of Psoriasis

David T. Robles, MD, PhD, FAAD


May 11, 2022

According to the AAD-NPF joint guidelines, monitoring should be conducted as follows in patients taking biologics:

  • Periodic history and physical examination, including screening for nonmelanoma skin cancer

  • Specific assessment for infections

  • Exacerbation/development of inflammatory bowel disease

  • Tuberculosis testing in persons at high risk owing to travel or contact with an infected individual

  • An annual chest radiograph may be considered at the discretion of the treating dermatologist

  • Periodic assessment of suicidal ideation is recommended for patients treated with brodalumab and might necessitate more frequent follow-up visits

Follow-up visits can be scheduled from quarterly to twice yearly on the basis of time of treatment, response, and tolerability of the medication.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.